ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Anal cancer
  • Artificial intelligence (AI)
  • Bladder cancer
  • Brain cancer
  • Breast cancer
  • Colorectal cancer
  • ComboMATCH
  • Esophagus cancer
  • Gallbladder cancer
  • Head and neck cancer
  • Health equity
  • Immunotherapy
  • In memory
  • Kidney cancer
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Penis cancer
  • Personalized treatment
  • Policy
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data/evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Upper tract urothelial cancer
  • Young adults
March 3, 2021
Man holding throat
March 3, 2021
Categories
  • New Trials

Now Enrolling: Clinical trial EA2174 is evaluating a new treatment approach for patients with esophagus cancer

This trial is testing if the addition of immunotherapy to the usual treatment will lead to better results for patients with esophagus or gastroesophagus cancer
Do you like it?
0 Read more
June 10, 2020
Valerie Guild headshot
June 10, 2020
Categories
  • Editorials

Remembering Valerie Guild, a tireless advocate for patients with melanoma

Valerie Guild was Founder and President of the non-profit organization AIM at Melanoma, and served as a patient advocate on ECOG-ACRIN’s Melanoma Committee for over ten years.
Do you like it?
0 Read more
June 6, 2020
June 6, 2020
Categories
  • Ongoing Trials

Ongoing Trial: EA3161 is testing maintenance immunotherapy versus observation in patients with HPV-related throat cancer

This trial is comparing chemotherapy and radiation to chemotherapy and radiation plus an immunotherapy drug.
Do you like it?
0 Read more
February 10, 2020
man with kidney pain
February 10, 2020
Categories
  • Ongoing Trials

Ongoing Trial: The PROSPER RCC kidney cancer trial seeks to transform treatment for patients with renal cell carcinoma

This trial is comparing immune system therapy before and after surgery to surgery alone.
Do you like it?
0 Read more
Prev page
12345678
Next page

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc